Filing Details
- Accession Number:
- 0001209191-20-050596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-15 19:25:19
- Reporting Period:
- 2020-09-14
- Accepted Time:
- 2020-09-15 19:25:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1785406 | Kathleen Ford | C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-09-14 | 6,250 | $19.43 | 6,250 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-09-14 | 6,250 | $29.43 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-09-15 | 6,250 | $19.43 | 6,250 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-09-15 | 6,250 | $29.43 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to purchase common stock | Disposition | 2020-09-14 | 6,250 | $0.00 | 6,250 | $19.43 |
Common Stock | Option to purchase common stock | Disposition | 2020-09-15 | 6,250 | $0.00 | 6,250 | $19.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
243,750 | 2029-08-08 | No | 4 | M | Direct | |
237,500 | 2029-08-08 | No | 4 | M | Direct |
Footnotes
- The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020.
- This option vests in 48 equal monthly installments commencing on August 9, 2019.